Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: AlzChem Group AG: AlzChem adjusts the forecast for fiscal year 2020 due to COVID-19


DGAP-Ad-hoc: AlzChem Group AG / Key word(s): Forecast/Change in Forecast
AlzChem Group AG: AlzChem adjusts the forecast for fiscal year 2020 due to COVID-19

14-Oct-2020 / 14:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Trostberg, October 14, 2020 - Due to the continuing economic effects of the COVID-19 pandemic in individual target industries and regions, AlzChem Group AG adjusts its forecast for fiscal year 2020. The continued very positive development, especially for Bioselect(R) products, which are among other things an essential component of the COVID-19 test kits, cannot fully compensate for these effects.

Therefore, the company now expects to generate stable to slightly declining consolidated sales compared to the previous year (original forecast: slightly rising to sharply rising). A similar development can be expected for adjusted EBITDA (original forecast: stable to sharply rising).


14-Oct-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: AlzChem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone: +498621862888
Fax: +49862186502888
E-mail: [email protected]
Internet: www.alzchem.com
ISIN: DE000A2YNT30
WKN: A2YNT3
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 1140885

 
End of Announcement DGAP News Service

1140885  14-Oct-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1140885&application_name=news&site_id=sharewise

AlzChem Group AG Stock

€45.60
1.110%
There is an upward development for AlzChem Group AG compared to yesterday, with an increase of €0.50 (1.110%).
Currently there is a rather positive sentiment for AlzChem Group AG with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 50 € shows a slightly positive potential of 9.65% compared to the current price of 45.6 € for AlzChem Group AG.
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments